Can a supercharged TB regimen save lives in HIV patients?
NCT ID NCT04738812
First seen Jan 07, 2026 · Last updated May 13, 2026 · Updated 16 times
Summary
This study tested whether a stronger tuberculosis (TB) treatment could reduce deaths in people with HIV who have very low CD4 counts (≤100). Over 1,300 hospitalized adults and teens received either an intensified regimen (higher doses of some TB drugs plus steroids) or the standard WHO TB treatment. The goal was to see if the stronger approach lowered death rates over 48 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ignace Deen Hospital
Conakry, Guinea
-
Jamot Hospital
Yaoundé, Cameroon
-
MACHAVA Hospital
Maputo, Mozambique
-
Mbarara Regional Referral hospital
Mbarara, Uganda
-
National Center for HIV/AIDS, Dermatology and STD (NCHADS)
Phnom Penh, Cambodia
-
University Teaching Hospital
Lusaka, Zambia
Conditions
Explore the condition pages connected to this study.